Literature DB >> 24418758

Recurrent mutations at C-reactive protein gene promoter SNP position -286 in human cancers.

Ming-Yu Wang1, Hai-Hong Zhou1, Shi-Chao Zhang1, Feng Hui1, Wei Zhu2, Hai-Xiang Su3, Hong-Yun Guo3, Xing-Wen Li3, Shang-Rong Ji1, Yi Wu4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24418758      PMCID： PMC3975510          DOI： 10.1038/cr.2014.7

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  10 in total

Review 1.  An integrated view of humoral innate immunity: pentraxins as a paradigm.

Authors:  Barbara Bottazzi; Andrea Doni; Cecilia Garlanda; Alberto Mantovani
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

Review 2.  Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer.

Authors:  Kristine H Allin; Børge G Nordestgaard
Journal:  Crit Rev Clin Lab Sci       Date:  2011 Jul-Aug       Impact factor: 6.250

3.  Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?

Authors:  Kurt Reifenberg; Hans-Anton Lehr; Daniela Baskal; Elena Wiese; Stephan C Schaefer; Steven Black; David Samols; Michael Torzewski; Karl J Lackner; Matthias Husmann; Maria Blettner; Sucharit Bhakdi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-05-26       Impact factor: 8.311

4.  C-reactive protein and the risk of cancer: a mendelian randomization study.

Authors:  Kristine H Allin; Børge G Nordestgaard; Jeppe Zacho; Anne Tybjaerg-Hansen; Stig E Bojesen
Journal:  J Natl Cancer Inst       Date:  2010-01-07       Impact factor: 13.506

5.  TERT promoter mutations in familial and sporadic melanoma.

Authors:  Susanne Horn; Adina Figl; P Sivaramakrishna Rachakonda; Christine Fischer; Antje Sucker; Andreas Gast; Stephanie Kadel; Iris Moll; Eduardo Nagore; Kari Hemminki; Dirk Schadendorf; Rajiv Kumar
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

6.  Highly recurrent TERT promoter mutations in human melanoma.

Authors:  Franklin W Huang; Eran Hodis; Mary Jue Xu; Gregory V Kryukov; Lynda Chin; Levi A Garraway
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

7.  C-reactive protein gene polymorphisms in disease susceptibility and clinical manifestations of Korean systemic lupus erythematosus.

Authors:  Hyoun-Ah Kim; Hye-Young Chun; Seung-Hyun Kim; Hae-Sim Park; Chang-Hee Suh
Journal:  J Rheumatol       Date:  2009-09-15       Impact factor: 4.666

8.  Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis.

Authors:  Jing Yang; Michele Wezeman; Xiang Zhang; Pei Lin; Michael Wang; Jianfei Qian; Bo Wan; Larry W Kwak; Long Yu; Qing Yi
Journal:  Cancer Cell       Date:  2007-09       Impact factor: 31.743

9.  Genetically elevated C-reactive protein and ischemic vascular disease.

Authors:  Jeppe Zacho; Anne Tybjaerg-Hansen; Jan Skov Jensen; Peer Grande; Henrik Sillesen; Børge G Nordestgaard
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

Review 10.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582
  10 in total
  7 in total

1.  An Intrinsically Disordered Motif Mediates Diverse Actions of Monomeric C-reactive Protein.

Authors:  Hai-Yun Li; Jing Wang; Fan Meng; Zhe-Kun Jia; Yang Su; Qi-Feng Bai; Ling-Ling Lv; Fu-Rong Ma; Lawrence A Potempa; Yong-Bin Yan; Shang-Rong Ji; Yi Wu
Journal:  J Biol Chem       Date:  2016-02-23       Impact factor: 5.157

2.  Topological localization of monomeric C-reactive protein determines proinflammatory endothelial cell responses.

Authors:  Hai-Yun Li; Jing Wang; Yue-Xin Wu; Lin Zhang; Zu-Pei Liu; János G Filep; Lawrence A Potempa; Yi Wu; Shang-Rong Ji
Journal:  J Biol Chem       Date:  2014-04-07       Impact factor: 5.157

3.  C-reactive protein directly suppresses Th1 cell differentiation and alleviates experimental autoimmune encephalomyelitis.

Authors:  Lin Zhang; Shan-Hui Liu; Tyler T Wright; Zhi-Yuan Shen; Hai-Yun Li; Wei Zhu; Lawrence A Potempa; Shang-Rong Ji; Alexander J Szalai; Yi Wu
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

4.  Evaluation of pro-inflammatory markers plasma C-reactive protein and urinary prostaglandin-E2 metabolite in colorectal adenoma risk.

Authors:  James R Davenport; Qiuyin Cai; Reid M Ness; Ginger Milne; Zhiguo Zhao; Walter E Smalley; Wei Zheng; Martha J Shrubsole
Journal:  Mol Carcinog       Date:  2015-08-31       Impact factor: 4.784

5.  Mutations of C-reactive protein (CRP) -286 SNP, APC and p53 in colorectal cancer: implication for a CRP-Wnt crosstalk.

Authors:  Hai-Xiang Su; Hai-Hong Zhou; Ming-Yu Wang; Jin Cheng; Shi-Chao Zhang; Feng Hui; Xue-Zhong Chen; Shan-Hui Liu; Qin-Jiang Liu; Zi-Jiang Zhu; Qing-Rong Hu; Yi Wu; Shang-Rong Ji
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

6.  Presence of multimeric isoforms of human C-reactive protein in tissues and blood.

Authors:  Qiling Li; Wei Xu; Xue Xue; Qi Wang; Lu Han; Wenzhi Li; Shulan Lv; Dong Liu; Jendai Richards; Zhujun Shen; Li Ma; Qing Song
Journal:  Mol Med Rep       Date:  2016-11-03       Impact factor: 2.952

7.  Reversible promoter methylation determines fluctuating expression of acute phase proteins.

Authors:  Shi-Chao Zhang; Ming-Yu Wang; Jun-Rui Feng; Yue Chang; Shang-Rong Ji; Yi Wu
Journal:  Elife       Date:  2020-03-30       Impact factor: 8.140
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.